489 related articles for article (PubMed ID: 29622397)
1. The route and timing of hydrogen sulfide therapy critically impacts intestinal recovery following ischemia and reperfusion injury.
Jensen AR; Drucker NA; Te Winkel JP; Ferkowicz MJ; Markel TA
J Pediatr Surg; 2018 Jun; 53(6):1111-1117. PubMed ID: 29622397
[TBL] [Abstract][Full Text] [Related]
2. Hydrogen Sulfide Donor GYY4137 Acts Through Endothelial Nitric Oxide to Protect Intestine in Murine Models of Necrotizing Enterocolitis and Intestinal Ischemia.
Drucker NA; Jensen AR; Te Winkel JP; Markel TA
J Surg Res; 2019 Feb; 234():294-302. PubMed ID: 30527488
[TBL] [Abstract][Full Text] [Related]
3. Hydrogen sulfide improves intestinal recovery following ischemia by endothelial nitric oxide-dependent mechanisms.
Jensen AR; Drucker NA; Khaneki S; Ferkowicz MJ; Markel TA
Am J Physiol Gastrointest Liver Physiol; 2017 May; 312(5):G450-G456. PubMed ID: 28280145
[TBL] [Abstract][Full Text] [Related]
4. Hydrogen sulfide provides intestinal protection during a murine model of experimental necrotizing enterocolitis.
Drucker NA; Jensen AR; Ferkowicz M; Markel TA
J Pediatr Surg; 2018 Sep; 53(9):1692-1698. PubMed ID: 29338840
[TBL] [Abstract][Full Text] [Related]
5. Parenteral Na
Drapala A; Koszelewski D; Tomasova L; Ostaszewski R; Grman M; Ondrias K; Ufnal M
Acta Biochim Pol; 2017; 64(3):561-566. PubMed ID: 28753683
[TBL] [Abstract][Full Text] [Related]
6. Effects of intranasal treatment with slow (GYY4137) and rapid (NaHS) donors of hydrogen sulfide in lipopolysaccharide-induced airway inflammation in mice.
Kaya-Yasar Y; Karaman Y; Bozkurt TE; Onder SC; Sahin-Erdemli I
Pulm Pharmacol Ther; 2017 Aug; 45():170-180. PubMed ID: 28645584
[TBL] [Abstract][Full Text] [Related]
7. Protective effect of GYY4137, a water‑soluble hydrogen sulfide‑releasing molecule, on intestinal ischemia‑reperfusion.
Cui N; Luo H; Zhao Y
Mol Med Rep; 2020 Mar; 21(3):1633-1639. PubMed ID: 32016475
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological postconditioning against myocardial infarction with a slow-releasing hydrogen sulfide donor, GYY4137.
Karwi QG; Whiteman M; Wood ME; Torregrossa R; Baxter GF
Pharmacol Res; 2016 Sep; 111():442-451. PubMed ID: 27378570
[TBL] [Abstract][Full Text] [Related]
9. GYY4137, a Slow-Releasing Hydrogen Sulfide Donor, Ameliorates Renal Damage Associated with Chronic Obstructive Uropathy.
Lin S; Visram F; Liu W; Haig A; Jiang J; Mok A; Lian D; Wood ME; Torregrossa R; Whiteman M; Lobb I; Sener A
J Urol; 2016 Dec; 196(6):1778-1787. PubMed ID: 27177428
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-21-Regulated Activation of the Akt Pathway Participates in the Protective Effects of H
Lu M; Jiang X; Tong L; Zhang F; Ma L; Dong X; Sun X
Biol Pharm Bull; 2018 Feb; 41(2):229-238. PubMed ID: 29187695
[TBL] [Abstract][Full Text] [Related]
11. Exogenous hydrogen sulfide (H2S) protects alveolar growth in experimental O2-induced neonatal lung injury.
Vadivel A; Alphonse RS; Ionescu L; Machado DS; O'Reilly M; Eaton F; Haromy A; Michelakis ED; Thébaud B
PLoS One; 2014; 9(3):e90965. PubMed ID: 24603989
[TBL] [Abstract][Full Text] [Related]
12. Hydrogen sulfide donor GYY4137 attenuates vascular complications in mesenteric bed of streptozotocin-induced diabetic rats.
Alshahwan H; Qabazard B; Mousa A; Chandrasekhar B; Santhosh K; Yousif MHM
Eur J Pharmacol; 2022 Oct; 933():175265. PubMed ID: 36108734
[TBL] [Abstract][Full Text] [Related]
13. Hydrogen sulfide ameliorates acute lung injury induced by infrarenal aortic cross-clamping by inhibiting inflammation and angiopoietin 2 release.
Tang B; Ma L; Yao X; Tan G; Han P; Yu T; Liu B; Sun X
J Vasc Surg; 2017 Feb; 65(2):501-508.e1. PubMed ID: 26781077
[TBL] [Abstract][Full Text] [Related]
14. Hydrogen Sulfide Is an Antiviral and Antiinflammatory Endogenous Gasotransmitter in the Airways. Role in Respiratory Syncytial Virus Infection.
Ivanciuc T; Sbrana E; Ansar M; Bazhanov N; Szabo C; Casola A; Garofalo RP
Am J Respir Cell Mol Biol; 2016 Nov; 55(5):684-696. PubMed ID: 27314446
[TBL] [Abstract][Full Text] [Related]
15. GYY4137, an Extended-Release Hydrogen Sulfide Donor, Reduces NMDA-Induced Neuronal Injury in the Murine Retina.
Sone K; Mori A; Sakamoto K; Nakahara T
Biol Pharm Bull; 2018; 41(4):657-660. PubMed ID: 29607941
[TBL] [Abstract][Full Text] [Related]
16. Daily therapy with a slow-releasing H
Lin S; Lian D; Liu W; Haig A; Lobb I; Hijazi A; Razvi H; Burton J; Whiteman M; Sener A
Nitric Oxide; 2018 Jun; 76():16-28. PubMed ID: 29522906
[TBL] [Abstract][Full Text] [Related]
17. Protective Effects of GYY4137 on Renal Ischaemia/Reperfusion Injury through Nrf2-Mediated Antioxidant Defence.
Zhao H; Qiu Y; Wu Y; Sun H; Gao S
Kidney Blood Press Res; 2021; 46(3):257-265. PubMed ID: 33910212
[TBL] [Abstract][Full Text] [Related]
18. H2S Attenuates LPS-Induced Acute Lung Injury by Reducing Oxidative/Nitrative Stress and Inflammation.
Zhang HX; Liu SJ; Tang XL; Duan GL; Ni X; Zhu XY; Liu YJ; Wang CN
Cell Physiol Biochem; 2016; 40(6):1603-1612. PubMed ID: 28006762
[TBL] [Abstract][Full Text] [Related]
19. Harvest tissue source does not alter the protective power of stromal cell therapy after intestinal ischemia and reperfusion injury.
Jensen AR; Manning MM; Khaneki S; Drucker NA; Markel TA
J Surg Res; 2016 Aug; 204(2):361-370. PubMed ID: 27565072
[TBL] [Abstract][Full Text] [Related]
20. Using mechanism-based combinations of H
Ravani S; Chatzianastasiou A; Papapetropoulos A
Naunyn Schmiedebergs Arch Pharmacol; 2024 Mar; 397(3):1853-1864. PubMed ID: 37773523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
